Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
Prevalence of non-valvular atrial fibrillation is increasing over time. Particularly in elderly population, treatment strategies to reduce the rate of stroke are challenging and still represent an unsolved cultural question. Indeed, the risk of thromboembolism increases in the elderly in parallel wi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2017-07-01
|
Series: | Geriatric Care |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/gc/article/view/6371 |
id |
doaj-8a4e31f2f49f4cecae2d3e446d27886b |
---|---|
record_format |
Article |
spelling |
doaj-8a4e31f2f49f4cecae2d3e446d27886b2020-11-25T03:39:10ZengPAGEPress PublicationsGeriatric Care2465-11092465-13972017-07-013210.4081/gc.2017.63715338Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged swordFrancesco Vetta0Gabriella Locorotondo1Giampaolo Vetta2Cardiology Unit, Israelite Hospital, RomeCardiology Unit, Israelite Hospital, Rome; Institute of Cardiology, Catholic University of the Sacred Heart, RomeCardiology Unit, Israelite Hospital, Rome; Institute of Cardiology, Campus Bio-Medico University, RomePrevalence of non-valvular atrial fibrillation is increasing over time. Particularly in elderly population, treatment strategies to reduce the rate of stroke are challenging and still represent an unsolved cultural question. Indeed, the risk of thromboembolism increases in the elderly in parallel with the risk of bleeding. The frequent coexistence of several morbidities, frailty syndrome, polypharmacy, chronic kidney disease and dementia strengthens the perception that risk-benefit ratio of anticoagulant therapy could be unfavorable, and explains why such treatment is underused in the elderly. Recently, the introduction of non-vitamin K oral anticoagulants (NOACs) has allowed us to overcome the large number of limitations imposed by the use of vitamin K antagonists. In this manuscript, the benefits of individual NOACs in comparison with warfarin in elderly patients are reviewed. Targeted studies on complex elderly patients are needed to test usefulness of a geriatric comprehensive assessment, besides the scores addressing risk of thromboembolic and hemorrhagic events. In the meantime, it is mandatory that use of anticoagulant therapy in most elderly people, currently excluded from randomized controlled trials, is prudent and responsible.http://www.pagepressjournals.org/index.php/gc/article/view/6371Atrial fibrillationnon-vitamin K antagonist oral anticoagulationwarfarinelderlystrokehemorrhagefrailty. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Francesco Vetta Gabriella Locorotondo Giampaolo Vetta |
spellingShingle |
Francesco Vetta Gabriella Locorotondo Giampaolo Vetta Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword Geriatric Care Atrial fibrillation non-vitamin K antagonist oral anticoagulation warfarin elderly stroke hemorrhage frailty. |
author_facet |
Francesco Vetta Gabriella Locorotondo Giampaolo Vetta |
author_sort |
Francesco Vetta |
title |
Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword |
title_short |
Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword |
title_full |
Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword |
title_fullStr |
Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword |
title_full_unstemmed |
Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword |
title_sort |
anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword |
publisher |
PAGEPress Publications |
series |
Geriatric Care |
issn |
2465-1109 2465-1397 |
publishDate |
2017-07-01 |
description |
Prevalence of non-valvular atrial fibrillation is increasing over time. Particularly in elderly population, treatment strategies to reduce the rate of stroke are challenging and still represent an unsolved cultural question. Indeed, the risk of thromboembolism increases in the elderly in parallel with the risk of bleeding. The frequent coexistence of several morbidities, frailty syndrome, polypharmacy, chronic kidney disease and dementia strengthens the perception that risk-benefit ratio of anticoagulant therapy could be unfavorable, and explains why such treatment is underused in the elderly. Recently, the introduction of non-vitamin K oral anticoagulants (NOACs) has allowed us to overcome the large number of limitations imposed by the use of vitamin K antagonists. In this manuscript, the benefits of individual NOACs in comparison with warfarin in elderly patients are reviewed. Targeted studies on complex elderly patients are needed to test usefulness of a geriatric comprehensive assessment, besides the scores addressing risk of thromboembolic and hemorrhagic events. In the meantime, it is mandatory that use of anticoagulant therapy in most elderly people, currently excluded from randomized controlled trials, is prudent and responsible. |
topic |
Atrial fibrillation non-vitamin K antagonist oral anticoagulation warfarin elderly stroke hemorrhage frailty. |
url |
http://www.pagepressjournals.org/index.php/gc/article/view/6371 |
work_keys_str_mv |
AT francescovetta anticoagulationtherapyintheelderlywithnonvalvularatrialfibrillationadoubleedgedsword AT gabriellalocorotondo anticoagulationtherapyintheelderlywithnonvalvularatrialfibrillationadoubleedgedsword AT giampaolovetta anticoagulationtherapyintheelderlywithnonvalvularatrialfibrillationadoubleedgedsword |
_version_ |
1724540402261819392 |